CIC completes 2-3 studies per year: avg. 50% crossover studies and 50% parallel studies.
Across the Collaborative and within each study site, CIC employs the expertise of all the highly-trained research, technical and clinical staff required […]
BRONCHOPROVOCATION Inhaled allergen (PC20/PD20, early & late asthmatic responses) Methacholine airway hyperresponsiveness Inhaled mannitol (Aridol®) Exercise-induced bronchoconstriction Hypertonic saline Capsaicin cough challenge […]
CIC has 6 sites across Canada and engagements with 5 international sites.